Oppenheimer Downgrades CVS Health Stock to ‘Perform’
Oppenheimer Downgrades CVS Health Stock to 'Perform'Near-term headwinds to set the directionOn April 15, Oppenheimer downgraded CVS Health (CVS) stock to “perform” from “outperform” and removed its price target of $85. CVS Health’s